AI-driven end-to-end drug discovery platform identifying novel targets and designing small molecules.
Why it matters
AI-discovered drugs are now in clinical trials, compressing drug discovery from years to months.
Know a brand or leader like this? Nominate them for Premier Brands, Asian Premier Brands and Leaders 2026. Entries close 16 October 2026.
Editorial profile compiled from public sources. Facts are confirmed with the subject before the profile is expanded, and the subject may request corrections at ceo@gceip.com.